Metabolic studies on a new antiepileptic drug, Riker 594.
D000927:Anticonvulsants; D003955:Diagnostic Tests, Routine; D006296:Health Services; D006801:Humans; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides
D000927:Anticonvulsants; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide
ANTICONVULSANTS; SULFONAMIDES